The interaction between methotrexate and probenecid in man [proceedings]. 1978

G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011339 Probenecid The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy. Benecid,Benemid,Benuryl,Pro-Cid,Probecid,Probenecid Weimer
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
January 1984, Pharmacology,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
August 1986, British journal of rheumatology,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
August 1979, Kidney international,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
September 1984, Cancer research,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
January 1977, Archives internationales de pharmacodynamie et de therapie,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
August 1984, Neuropharmacology,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
May 2002, Journal of pediatric hematology/oncology,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
September 1978, Clinical pharmacology and therapeutics,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
July 1971, Annals of the New York Academy of Sciences,
G W Aherne, and V Marks, and G P Mould, and E Piall, and W F White
January 2008, Clinical pharmacokinetics,
Copied contents to your clipboard!